Short answer
Anteris Technologies Global Corp. (AVR) filed an 8-K current report with the SEC on September 8, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Brent Moen appointed CFO effective September 11, 2026, bringing 25+ years’ financial leadership across medical technology companies.
Anteris Technologies Global Corp. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Brent Moen appointed CFO effective September 11, 2026, bringing 25+ years’ financial leadership across medical technology companies
- Base salary $475,000 with short-term bonus opportunity up to 50% of salary, prorated for 2026
- 2026 long-term incentive award target value $500,000 through nonqualified stock options vesting over three years
- Severance includes nine months’ salary continuation and COBRA reimbursement upon termination without cause
- Matthew McDonnell transitions to Head of Australia, ending his CFO tenure while remaining employed under existing compensation terms
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Anteris Technologies Global Corp. 8-K filings
Get the next AVR 8-K as it lands
Follow AVR for push alerts, or ask the research agent what this filing means.